Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gunshot Wounds of the Abdomen.

The Chicago medical journal and examiner·2023
Same author

The Use of the Murphy Button.

The Southern medical record·2022
Same author

Feeding dicyandiamide (DCD) to cattle: An effective method to reduce N<sub>2</sub>O emissions from urine patches in a heavy-textured soil under temperate climatic conditions.

The Science of the total environment·2018
Same author

Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence population.

Epidemiology and infection·2018
Same author

Spatiotemporal Co-occurrence of Flanders and West Nile Viruses Within Culex Populations in Shelby County, Tennessee.

Journal of medical entomology·2016
Same author

An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years.

Epidemiology and infection·2015
Same journal

Brown's cadmuses of the blind.

Rhode Island medicine·1995
Same journal

Too good to be true? New technologies and surgical procedures for better vision.

Rhode Island medicine·1995
Same journal

In-office temporal artery biopsy.

Rhode Island medicine·1995
Same journal

Ocular disorders in women.

Rhode Island medicine·1995
Same journal

Ophthalmic complications of systemic disease.

Rhode Island medicine·1995
Same journal

Six signs in children with life-threatening implications.

Rhode Island medicine·1995
See all related articles

Related Experiment Video

Updated: May 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Screening for older persons

J B Murphy1, T F Jones

  • 1Division of Geriatrics, Brown University Department of Family Medicine.

Rhode Island Medicine
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

This study provides screening recommendations for older adults, prioritizing proven interventions over unproven strategies to maximize resource effectiveness and patient safety. Focus is on improving current screening rates for established methods.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Oral Health Assessment by Lay Personnel for Older Adults
08:47

Oral Health Assessment by Lay Personnel for Older Adults

Published on: February 2, 2020

Related Experiment Videos

Last Updated: May 8, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Oral Health Assessment by Lay Personnel for Older Adults
08:47

Oral Health Assessment by Lay Personnel for Older Adults

Published on: February 2, 2020

Area of Science:

  • Gerontology
  • Preventive Medicine
  • Public Health

Background:

  • Older individuals require tailored screening strategies.
  • Current screening practices may not reach all target populations effectively.
  • Concerns exist regarding the potential harms of unproven screening methods.

Purpose of the Study:

  • To outline evidence-based screening recommendations for older adults.
  • To advocate for resource allocation towards proven screening interventions.
  • To address the underutilization of existing effective screening strategies.

Main Methods:

  • Development of screening recommendations based on established efficacy.
  • Analysis of resource allocation priorities in preventive healthcare.
  • Review of current screening rates and potential barriers.

Main Results:

  • Screening recommendations emphasize proven interventions (Figures 1 and 2).
  • A parsimonious approach is proposed, focusing on high-yield screening strategies.
  • Prioritization of improving screening rates for efficacious interventions is recommended.

Conclusions:

  • Investment in unproven screening strategies should be deferred.
  • Enhancing screening rates for established interventions is a more prudent use of resources.
  • Recommendations aim to optimize health outcomes and minimize potential harms in older adults.